Experiment: 2I38

SOLUTION NMR

NMR Experiment
Experiment	Type	Sample Contents	Solvent	Ionic Strength	pH	Pressure	Temperature (K)	Spectrometer
1	2D NOESY	1mM SRp20 15N labelled in 50 mM sodium dihydrogenophosphate, pH 5.8, 1mM DTT;	10% D2O, 90% H2O or 100% D2O		5.8	ambient	315
2	HNCA	1mM SRp20 13C-15N labelled in 50 mM sodium dihydrogenophosphate, pH 5.8, 1mM DTT;	10% D2O, 90% H2O or 100% D2O		5.8	ambient	315
3	CBCA(CO)NH	1mM SRp20 13C-15N labelled in 50 mM sodium dihydrogenophosphate, pH 5.8, 1mM DTT;	10% D2O, 90% H2O or 100% D2O		5.8	ambient	315
4	3D_15N-separated_NOESY	1mM SRp20 15N labelled in 50 mM sodium dihydrogenophosphate, pH 5.8, 1mM DTT;	10% D2O, 90% H2O or 100% D2O		5.8	ambient	315
5	3D_13C-separated_NOESY	1mM SRp20 13C-15N labelled in 50 mM sodium dihydrogenophosphate, pH 5.8, 1mM DTT;	10% D2O, 90% H2O or 100% D2O		5.8	ambient	315
6	HCCH TOCSY	1mM SRp20 13C-15N labelled in 50 mM sodium dihydrogenophosphate, pH 5.8, 1mM DTT;	10% D2O, 90% H2O or 100% D2O		5.8	ambient	315
7	2D 1H-15N HSQC	1mM SRp20 15N labelled in 50 mM sodium dihydrogenophosphate, pH 5.8, 1mM DTT;	10% D2O, 90% H2O or 100% D2O		5.8	ambient	315
8	2D TOCSY	1mM SRp20 15N labelled in 50 mM sodium dihydrogenophosphate, pH 5.8, 1mM DTT;	10% D2O, 90% H2O or 100% D2O		5.8	ambient	315
9	2D 1H-13C HSQC	1mM SRp20 13C-15N labelled in 50 mM sodium dihydrogenophosphate, pH 5.8, 1mM DTT;	10% D2O, 90% H2O or 100% D2O		5.8	ambient	315

NMR Spectrometer Information
Spectrometer	Manufacturer	Model	Field Strength
1	Bruker	DRX	900
2	Bruker	DRX	600
3	Bruker	DRX	500

NMR Refinement
Method	Details	Software
SANDER module of AMBER 7	generalized-Born solvation model	DYANA

NMR Ensemble Information
Conformer Selection Criteria	structures with the least restraint violations
Conformers Calculated Total Number	50
Conformers Submitted Total Number	19
Representative Model	1 (closest to the average)

Computation: NMR Software
#	Classification	Version	Software Name	Author
1	structure solution	DYANA
2	data analysis	Sparky
3	refinement	Amber 7		Case and Cornell

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.